Literature DB >> 33674612

Dynamic control of the dopamine transporter in neurotransmission and homeostasis.

Mengfei Bu1, Matthew J Farrer2, Habibeh Khoshbouei3.   

Abstract

The dopamine transporter (DAT) transports extracellular dopamine into the intracellular space contributing to the regulation of dopamine neurotransmission. A reduction of DAT density is implicated in Parkinson's disease (PD) by neuroimaging; dopamine turnover is dopamine turnover is elevated in early symptomatic PD and in presymptomatic individuals with monogenic mutations causal for parkinsonism. As an integral plasma membrane protein, DAT surface expression is dynamically regulated through endocytic trafficking, enabling flexible control of dopamine signaling in time and space, which in turn critically modulates movement, motivation and learning behavior. Yet the cellular machinery and functional implications of DAT trafficking remain enigmatic. In this review we summarize mechanisms governing DAT trafficking under normal physiological conditions and discuss how PD-linked mutations may disturb DAT homeostasis. We highlight the complexity of DAT trafficking and reveal DAT dysregulation as a common theme in genetic models of parkinsonism.

Entities:  

Year:  2021        PMID: 33674612     DOI: 10.1038/s41531-021-00161-2

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  150 in total

1.  Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.

Authors:  Wakoto Matsuda; Takahiro Furuta; Kouichi C Nakamura; Hiroyuki Hioki; Fumino Fujiyama; Ryohachi Arai; Takeshi Kaneko
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

2.  Space, time and dopamine.

Authors:  Gordon W Arbuthnott; Jeff Wickens
Journal:  Trends Neurosci       Date:  2006-12-13       Impact factor: 13.837

3.  Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.

Authors:  Vesna Sossi; Raúl de La Fuente-Fernández; James E Holden; Doris J Doudet; Jess McKenzie; A J Stoessl; T J Ruth
Journal:  J Cereb Blood Flow Metab       Date:  2002-02       Impact factor: 6.200

4.  Immunocytochemical localization of the dopamine transporter in human brain.

Authors:  B J Ciliax; G W Drash; J K Staley; S Haber; C J Mobley; G W Miller; E J Mufson; D C Mash; A I Levey
Journal:  J Comp Neurol       Date:  1999-06-21       Impact factor: 3.215

Review 5.  Dopamine receptor subtypes: beyond the D1/D2 classification.

Authors:  P H Andersen; J A Gingrich; M D Bates; A Dearry; P Falardeau; S E Senogles; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

6.  Dopamine turnover increases in asymptomatic LRRK2 mutations carriers.

Authors:  Vesna Sossi; Raul de la Fuente-Fernández; Ramachandiran Nandhagopal; Michael Schulzer; Jessamyn McKenzie; Thomas J Ruth; Jan O Aasly; Matthew J Farrer; Zbigniew K Wszolek; Jon A Stoessl
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

7.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

Authors:  C S Lee; A Samii; V Sossi; T J Ruth; M Schulzer; J E Holden; J Wudel; P K Pal; R de la Fuente-Fernandez; D B Calne; A J Stoessl
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

Review 8.  DAncing past the DAT at a DA synapse.

Authors:  Stephanie J Cragg; Margaret E Rice
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

Review 9.  Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Brain Res Rev       Date:  2008-03-06

10.  Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.

Authors:  Daryl J Wile; Pankaj A Agarwal; Michael Schulzer; Edwin Mak; Katherine Dinelle; Elham Shahinfard; Nasim Vafai; Kazuko Hasegawa; Jing Zhang; Jessamyn McKenzie; Nicole Neilson; Audrey Strongosky; Ryan J Uitti; Mark Guttman; Cyrus P Zabetian; Yu-Shin Ding; Mike Adam; Jan Aasly; Zbigniew K Wszolek; Matthew Farrer; Vesna Sossi; A Jon Stoessl
Journal:  Lancet Neurol       Date:  2017-03-20       Impact factor: 44.182

View more
  9 in total

Review 1.  Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Authors:  Douglas R Miller; Mengfei Bu; Adithya Gopinath; Luis R Martinez; Habibeh Khoshbouei
Journal:  J Pharmacol Exp Ther       Date:  2021-09-17       Impact factor: 4.402

2.  Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.

Authors:  Charles Sutton; Erin Q Williams; Hoomam Homsi; Pieter Beerepoot; Reza Nazari; Dong Han; Amy J Ramsey; Deborah C Mash; David E Olson; Bruce Blough; Ali Salahpour
Journal:  Front Cell Neurosci       Date:  2022-05-09       Impact factor: 6.147

3.  Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice.

Authors:  Chiara Domenicale; Daniela Mercatelli; Federica Albanese; Salvatore Novello; Fabrizio Vincenzi; Katia Varani; Michele Morari
Journal:  Biomedicines       Date:  2022-04-12

4.  An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Drosophila melanogaster.

Authors:  Rafaella V Zárate; Sergio Hidalgo; Nicole Navarro; Daniela Molina-Mateo; Duxan Arancibia; Francisca Rojo-Cortés; Carlos Oliva; María Estela Andrés; Pedro Zamorano; Jorge M Campusano
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

5.  Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline.

Authors:  Clarissa Catale; Luisa Lo Iacono; Alessandro Martini; Constantin Heil; Ezia Guatteo; Nicola Biagio Mercuri; Maria Teresa Viscomi; Daniela Palacios; Valeria Carola
Journal:  Mol Neurobiol       Date:  2022-04-18       Impact factor: 5.682

Review 6.  Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease.

Authors:  José Ángel Martínez-Menárguez; Emma Martínez-Alonso; Mireia Cara-Esteban; Mónica Tomás
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

7.  The Lack of Dopamine Transporter Is Associated With Conditional Associative Learning Impairments and Striatal Proteomic Changes.

Authors:  Artem Savchenko; Carina Müller; Jana Lubec; Damiana Leo; Volker Korz; Leila Afjehi-Sadat; Jovana Malikovic; Fernando J Sialana; Gert Lubec; Ilya Sukhanov
Journal:  Front Psychiatry       Date:  2022-03-18       Impact factor: 4.157

8.  A New Method for the Visualization of Living Dopaminergic Neurons and Prospects for Using It to Develop Targeted Drug Delivery to These Cells.

Authors:  Victor Blokhin; Alina V Lavrova; Sergey A Surkov; Eduard R Mingazov; Natalia M Gretskaya; Vladimir V Bezuglov; Michael V Ugrumov
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

Review 9.  Retromer dependent changes in cellular homeostasis and Parkinson's disease.

Authors:  Zhe Yang; Zebin Li; Rohan D Teasdale
Journal:  Essays Biochem       Date:  2021-12-22       Impact factor: 8.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.